• News
  • India News
  • GLP-1 gold rush under scanner: Raids across India expose easy access to weight-loss drugs

GLP-1 gold rush under scanner: Raids across India expose easy access to weight-loss drugs

 Govt Tightens Grip On GLP-1 Weight Loss Drugs Amid Rising Concerns Over Unauthorised Sales
Representative image (AI-generated)
NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of India’s drug regulator, with a series of raids across the country revealing just how easily these prescription medicines are finding their way to consumers.In recent weeks, inspections at 49 locations—ranging from online pharmacy warehouses and wholesalers to retail chemists and wellness clinics—have uncovered gaps in how GLP-1 drugs are being sold and promoted. For many, what should be a tightly regulated treatment is fast turning into an on-demand product.
Watch
Govt Tightens Grip On GLP-1 Weight Loss Drugs Amid Rising Concerns Over Unauthorised Sales
Originally developed for diabetes and certain heart conditions, GLP-1 drugs have surged in popularity as weight-loss solutions, fuelled by social media buzz and rising demand for quick results. Their growing presence in the Indian market, especially with the entry of generic versions, has only made them more accessible. But that accessibility is now raising serious concerns.Officials say the Drugs Controller General of India, along with state regulators, has stepped in to curb misuse and plug loopholes in the supply chain. The focus is on stopping sales without prescriptions, checking questionable dispensing practices and cracking down on misleading promotions.
What has particularly alarmed authorities is the widening network through which these drugs are being accessed—not just pharmacies, but also online platforms and slimming clinics, often without adequate medical oversight.Earlier this month, the regulator issued a clear warning to manufacturers, banning surrogate advertising and indirect promotions that could encourage off-label use or mislead consumers.Doctors caution that these are not lifestyle products. Taken without proper supervision, GLP-1 drugs can lead to serious side effects, making self-medication risky.Regulators have reiterated that the drugs are approved in India only under strict conditions and must be prescribed by specialists such as endocrinologists or internal medicine experts, and in some cases cardiologists.With demand continuing to grow, officials say enforcement will only get stricter. Licences could be cancelled, penalties imposed and legal action initiated against violators.
author
About the AuthorAnuja Jaiswal

Anuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.

End of Article
Follow Us On Social Media